Re: Farmas USA
Adxs
Update (especie de “eh! Que aún estamos aquí haciendo cosas!”)
https://www.businesswire.com/news/home/20181102005079/en/Advaxis-Update-Clinical-Pipeline
Continuing its Phase 3 AIM2CERV Study
Anticipates Data on ADXS-PSA, ADXS-NEO and ADXS-HOT (NSCLC) in 2019
Conference Call Today at 11:00 a.m. Eastern Time